Robust measurement of clinical improvement in patients with cutaneous lupus erythematosus
Objective The severity and disease course of cutaneous lupus erythematosus (CLE) are highly variable. Consequently, outcome measures for CLE clinical improvement are heterogeneous, complicating treatment decisions and therapeutic development. This study characterises CLE outcome measures and identif...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2020-12-01
|
Series: | Lupus Science and Medicine |
Online Access: | https://lupus.bmj.com/content/7/1/e000364.full |